Identifying symptomatic adverse events using the patient‐reported outcomes version of the common terminology criteria for adverse events in patients with non‐small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations

Identifying symptomatic adverse events using the patient‐reported outcomes version of the common terminology criteria for adverse events in patients with non‐small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations

Abstract Objective Tolerability and safety of treatments are important in oncology trials and should be informed by patient assessments. We identified the most relevant patient‐reported symptomatic adverse events (AEs) to measure in patients with non‐small cell lung cancer (NSCLC) with epidermal gro...

Full description

Bibliographic Details
Main Authors: Yanyan Zhu, Milenka Jean‐Baptiste, William R. Lenderking, Jill A. Bell, Dennis A. Revicki, Huamao M. Lin, Rachael Brake, Bryce B. Reeve
Format: Article
Language:English
Published: Wiley 2023-03-01
Series:Cancer Medicine
Subjects:
adverse events
non‐small cell lung cancer
oncology
patient‐reported outcome measures
PRO‐CTCAE
symptoms
Online Access:https://doi.org/10.1002/cam4.5376

Internet

https://doi.org/10.1002/cam4.5376

Similar Items